BRAIN AG announces strategic collaboration with BluCon Biotech GmbH

Joint R&D work aims at microbial strain development for the production of high-value chemicals including bioplastics

19-Sep-2018 - Germany

BRAIN AG announced the start of a strategic research and development collaboration with BluCon Biotech GmbH. The objective of the joint research efforts is the identification and development of special microbial production strains. The collaboration will run several months with the option for extension and prolongation after reaching agreed milestones.

BluCon Biotech GmbH develops a consolidated bioprocess for the production of lactic acid from industrial or agricultural cellulosic waste based on the company’s proprietary bacteria. BluCon’s objective is to achieve very low production costs in order to allow the production of PLA-based bioplastic (poly lactic acid) at costs competitive to fossil fuel-based plastics.

The aim of the R&D collaboration is the further improvement of BluCon’s microorganisms with classical biotechnologies enabling them to produce within their metabolisms the required product in a highly efficient manner.

Other news from the department business & finance

Most read news

More news from our other portals

So close that even
molecules turn red...